Global Transdermal Drug Delivery System Market (Patches, Gels)

Global Transdermal Drug Delivery System Market: Analysis By Type (Patches, Gels), By Technique (Ionophoresis, Electroporation, Sonophoresis, Others), By End-User, By Region, By Country (2018 Edition): Trends, Opportunities and Forecast (2013-2023)

• By End User- Hospital & Clinic, Healthcare

• By Region - North America, Europe, Asia Pacific and ROW. • By Country - U.S, Canada, U.K, Germany, Japan, India, China , Brazil.

1 November 2018

Scope of the Report – Transdermal Drug Delivery System Market Historical

Forecast

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

Patches























Gels























Iontophoresis Electroporation Sonophoresis Others

   

   

   

   

   

   

   

   

   

   

   

Hospital & Clinic























Homecare























Patches























Gels























Iontophoresis























Electroporation























Sonophoresis























Others























Hospital & Clinic























Homecare























Patches























Gels























Iontophoresis























Electroporation























Sonophoresis























Others























Hospital & Clinic























Market (By Value)

Global

By Type,

By Value

By Technique,

By Value

By End User

Regional

By Type,

By Value

By Technique,

By Value

By End User

Country

By Type,

By Value

By Technique,

By Value

By End User

Company Analysis

Homecare            3 M Pharmaceutical, Boehringer Ingelheim, Mylan, Novartis, GlaxoSmithKline, Noven, Lohmann Therapeutic Systems, Johnson& Johnson,, Bayer, Corium International.

Regional Analysis Country Analysis

North America, Europe, APAC and ROW U.S, Canada, India, China,Germany, U.K., Brazil and Japan

2

Table of Content S.No

Particulars

Page No.

1.

Research Methodology

23

2.

Executive Summary

24

3.

Strategic Recommendation

25

3.1

Increase bioavailability of poor penetration drugs and increase application of transdermal drug delivery system

26

3.2

APAC region to witness augmented growth in the forecast period

27

4.

Transdermal Drug Delivery System Outlook

28

5.

Transdermal Drug Delivery System Market: Growth and Forecast

37

6.

5.1

By Value (2013-2017)

38

5.2

By Value (2018-2023)

39

Transdermal Drug Delivery System Market: Segmental Analysis 6.1

Transdermal Drug Delivery System Market Size, By Type: Breakdown (%)

49 49

6.1.1

Transdermal Drug Delivery System Market Size, By Type, 2017 (%)

51

6.1.2

Transdermal Drug Delivery System Market Size, By Type, 2023 (%)

52

6.2

Global Patches Type Market Size, By Value (2013-2023)

53

6.3

Global Gels Type Market Size, By Value (2013-2023)

54

3

Table of Content S.No

Particulars 6.4

Page No.

Global Transdermal Drug Delivery System Market Size, By Technique : Breakdown(%)

55

6.4.1

56

6.4.2

Transdermal Drug Delivery System Market Size, By Technique, 2017 (%) Transdermal Drug Delivery System Market Size, By Technique, 2023 (%)

57

6.5

Global Iontophoresis Technique TDDS Market Size, By Value (2013-2023)

58

6.6

Global Electroporation Technique TDDS Market Size, By Value (2013-2023)

59

6.7

Global Sonophoresis Technique TDDS Market Size, By Value (2013-2023)

60

6.8

Global Others Technique TDDS Market Size, By Value (2013-2023)

61

6.9

Global Transdermal Drug Delivery System Market Size, By End User: Breakdown (%)

62

6.9.1

Transdermal Drug Delivery System System Market Size, By End User, 2017 (%)

63

6.9.2

Transdermal Drug Delivery System System Market Size, By End User , 2023 (%)

64

6.10

Global Hospital & Clinic Transdermal Drug Delivery System Market Size, By Value (2013-2023)

65

6.11

Global Homecare Transdermal Drug Delivery System Market Size, By Value (2013-2023)

66

Transdermal Drug Delivery System Market: Regional Analysis

67

Transdermal Drug Delivery System Market Size, By Region : Breakdown (%)

68

7.1.1

69

7.

7.1

Transdermal Drug Delivery System Market Size, By Region, 2017 (%)

4

Table of Content S.No

Particulars

7.1.2 7.2

7.3

Page No.

Transdermal Drug Delivery System Market Size, By Region, 2023 (%)

70

North America Transdermal Drug Delivery System Market: Growth and Forecast

71

7.2.1

By Value (2013-2017)

72

7.2.2

By Value (2018-2023)

73

7.2.3

By Type, By Value (2013-2017)

78

7.2.4

By Type, By Value (2018-2023)

79

7.2.5

By Technique, By Value (2013-2017)

80

7.2.6

By Technique, By Value (2018-2023)

81

7.2.7

By End User, By Value (2013-2017)

82

7.2.8

By End User, By Value (2018-2023)

83

North America Transdermal Drug Delivery System Market: Country Analysis (U.S and Canada)

84

7.3.1

U.S. Transdermal Drug Delivery System Market, By Value (2013-2023)

86

7.3.2

U.S. Transdermal Drug Delivery System Market, By Type, By Value (2013-2017)

92

7.3.3

U.S. Transdermal Drug Delivery System Market, By Type, By Value (2018-2023)

93

7.3.4

U.S. Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017)

94

5

Table of Content S.No

Particulars

7.4

Page No.

7.3.5

U.S. Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023)

95

7.3.6

U.S. Transdermal Drug Delivery System Market, By End User, By Value (2013-2017)

97

7.3.7

U.S. Transdermal Drug Delivery System Market, By End User, By Value (2018-2023)

98

7.3.8

Canada Transdermal Drug Delivery System Market, By Value (2013-2023)

100

7.3.9

Canada Transdermal Drug Delivery System Market, By Type, By Value (2013-2017)

104

7.3.10

Canada Transdermal Drug Delivery System Market, By Type, By Value (2018-2023)

105

7.3.11

Canada Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017)

106

7.3.12

Canada Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023)

107

7.3.13

Canada Transdermal Drug Delivery System Market, By End User, By Value (2013-2017)

109

7.3.14

Canada Transdermal Drug Delivery System Market, By End User, By Value (2018-2023)

110

Europe Transdermal Drug Delivery System Market: Growth and Forecast

113

7.4.1

By Value (2013-2017)

114

7.4.2

By Value (2018-2023)

115

7.4.3

By Type, By Value (2013-2017)

120

7.4.4

By Type, By Value (2018-2023)

121

6

Table of Content S.No

Page No.

7.5

7.4.5

By Technique, By Value (2013-2017)

122

7.4.6

By Technique, By Value (2018-2023)

123

7.4.7

By End User, By Value (2013-2017)

125

7.4.8

By End User, By Value (2018-2023)

126

Europe Transdermal Drug Delivery System Market: Country Analysis (U.K and Germany)

127

7.5.1

U.K. Transdermal Drug Delivery System Market, By Value (2013-2023)

129

7.5.2

U.K. Transdermal Drug Delivery System Market, By Type, By Value (2013-2017)

133

7.5.3

U.K. Transdermal Drug Delivery System Market, By Type, By Value (2018-2023)

134

7.5.4

U.K. Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017)

135

7.5.5

U.K. Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023)

136

7.5.6

U.K. Transdermal Drug Delivery System Market, By End User, By Value (2013-2017)

138

7.5.7

U.K. Transdermal Drug Delivery System Market, By End User, By Value (2018-2023)

139

7.5.8

Germany Transdermal Drug Delivery System Market, By Value (2013-2023)

141

7.5.9

Germany Transdermal Drug Delivery System Market, By Type, By Value (2013-2017)

146

7.5.10

Germany Transdermal Drug Delivery System Market, By Type, By Value (2018-2023)

147

7

Table of Content S.No

Page No.

7.6

7.7

7.5.11

Germany Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017)

148

7.5.12

Germany Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023)

149

7.5.13

Germany Transdermal Drug Delivery System Market, By End User, By Value (2013-2017)

151

7.5.14

Germany Transdermal Drug Delivery System Market, By End User, By Value (2018-2023)

152

APAC Transdermal Drug Delivery System Market: Growth and Forecast

154

7.6.1

By Value (2013-2017)

155

7.6.2

By Value (2018-2023)

156

7.6.3

By Type, By Value (2013-2017)

161

7.6.4

By Type, By Value (2018-2023)

162

7.6.5

By Technique, By Value (2013-2017)

163

7.6.6

By Technique, By Value (2018-2023)

164

7.6.7

By End user, By Value (2013-2017)

165

7.6.8

By End user, By Value (2018-2023)

165

APAC Transdermal Drug Delivery System Market: Country Analysis (Japan, India and China) 7.7.1

Japan Transdermal Drug Delivery System Market, By Value (2013-2023)

167 167

8

Table of Content S.No

Particulars

Page No.

7.7.2

Japan Transdermal Drug Delivery System Market, By Type, By Value (2013-2017)

175

7.7.3

Japan Transdermal Drug Delivery System Market, By Type, By Value (2018-2023)

176

7.7.4

Japan Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017)

177

7.7.5

Japan Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023)

178

7.7.4

Japan Transdermal Drug Delivery System Market, By End user, By Value (2013-2017)

180

7.7.5

Japan Transdermal Drug Delivery System Market, By End user, By Value (2018-2023)

181

7.7.6

India Transdermal Drug Delivery System Market, By Value (2013-2023)

183

7.7.7

India Transdermal Drug Delivery System Market, By Type, By Value (2013-2017)

189

7.7.8

India Transdermal Drug Delivery System Market, By Type, By Value (2018-2023)

190

7.7.9

India Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017)

191

7.7.10

India Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023)

192

7.7.11

India Transdermal Drug Delivery System Market, By End user,, By Value (2013-2017)

194

7.7.12

India Transdermal Drug Delivery System Market, By End user, By Value (2018-2023)

195

7.7.13

China Transdermal Drug Delivery System Market, By Value (2013-2023)

197

7.7.14

China Transdermal Drug Delivery System Market, By Type, By Value (2013-2017)

202

9

Table of Content S.No

Particulars

7.8

7.9

Page No.

7.7.15

China Transdermal Drug Delivery System Market, By Type, By Value (2018-2023)

203

7.7.16

China Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017)

204

7.7.17

China Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023)

205

7.7.18

China Transdermal Drug Delivery System Market, By End User, By Value (2013-2017)

207

7.7.19

China Transdermal Drug Delivery System Market, By End User, By Value (2018-2023)

208

ROW Transdermal Drug Delivery System Market: Growth and Forecast

211

7.8.1

By Value (2013-2017)

211

7.8.2

By Value (2018-2023)

211

7.8.3

By Type, By Value (2013-2017)

216

7.8.4

By Type, By Value (2018-2023)

217

7.8.5

By Technique, By Value (2013-2017)

218

7.8.6

By Technique, By Value (2018-2023)

219

7.8.7

By End User, By Value (2013-2017)

221

7.8.8

By End User, By Value (2018-2023)

222

ROW Transdermal Drug Delivery System Market: Country Analysis (Brazil)

223

10

Table of Content S. No.

8.

9.

Particulars

Page No.

7.9.1

Brazil Transdermal Drug Delivery System Market, By Value (2013-2023)

224

7.9.2

Brazil Transdermal Drug Delivery System Market, By Type, By Value (2013-2017)

227

7.9.3

Brazil Transdermal Drug Delivery System Market, By Type, By Value (2018-2023)

228

7.9.4

Brazil Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017)

229

7.9.5

Brazil Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023)

230

7.9.6

Brazil Transdermal Drug Delivery System Market, By End User, By Value (2013-2017)

232

7.9.7

Brazil Transdermal Drug Delivery System Market, By End User, By Value (2018-2023)

233

Transdermal Drug Delivery System Market Dynamics

234

8.1

Transdermal Drug Delivery System Market Drivers

235

8.2

Transdermal Drug Delivery System Market Restraints

240

8.3

Transdermal Drug Delivery System Market Trends

243

Porter Five Force Analysis

247

10.

SWOT Analysis

249

11.

Supply Chain Analysis

251

12.

Policy and Regulatory Landscape

253

11

Table of Content S.No 13.

Particulars Company Profiling

262

13.1

3 M Pharmaceutical

263

13.2

Boehringer Ingelheim

265

13.3

Mylan

267

13.4

Novartis

269

13.5

GlaxoSmithKline

271

13.6

Noven

273

13.7

Lohmann Therapeutics System

274

13.8

Johnson & Johnson

275

13.9

Bayer AG

277

Corium International

279

13.10 14.

Page No.

About Us

280

12

List of Figures Figure No.

Figure Title

Page No.

Figure 1:

Key Facts on Global Health Risk Diseases

36

Figure 2:

Global Transdermal Drug Delivery System System Market Size, By Value, 2013-2017 (USD Billion)

38

Figure 3:

Global Transdermal Drug Delivery System System Market Size, By Value, Forecast, 2018-2023 (USD Billion)

39

Figure 4:

Prevalence of hypertension, By Region, 2018( In %)

42

Figure 5:

Worldwide projection of Alzheimer prevalence 2005-2050 (In Million)

43

Figure 6:

Distribution of Cardiovascular disease deaths, 2015 (In %)

43

Figure 7:

Consequences of uncontrolled hypertension

44

Figure 8:

Prevalence of Smoking, By Country, 2016 (In %)

45

Figure 9:

Distribution of Abortions across Globe, 2015 (In %)

46

Figure 10:

GDP Per Capita PPP, By Region, 2018 (in Thousand USD)

47

Figure 11:

GDP Per Capita PPP, By Select Countries, 2022F (USD)

47

Figure 12:

Healthcare Expenditure (Share of GDP), By Select Country, 2013-2017 (In %)

48

Figure 13:

Transdermal Drug Delivery System System Market Size, By Type, 2017 (In %)

51

Figure 14:

Transdermal Drug Delivery System System Market Size, By Type, 2023 (In %)

52

Figure 15:

Global Patches Type Market, By Value, 2013-2017 (USD Billion)

53

Figure 16:

Global Patches Type Market, By Value, Forecast, 2018-2023(USD Billion)

53

Figure 17:

Global Gels Type Market, By Value, 2013-2017 (USD Billion)

54

Figure 18:

Global Gels Type Market, By Value, Forecast, 2018-2023(USD Billion)

54

Figure 19:

Transdermal Drug Delivery System Market Size, By Technique, 2017 (In %)

56

Figure 20:

Transdermal Drug Delivery System System Market Size, By Technique, 2023 (In %)

57

13

List of Figures Figure No.

Figure Title

Page No.

Figure 21:

Global Iontophoresis Technique TDDS Market, By Value, 2013-2017 (USD Billion)

58

Figure 22:

Global Iontophoresis Technique TDDS Market, By Value, Forecast, 2018-2023(USD Billion)

58

Figure 23:

Global Electroporation Technique Market, By Value, 2013-2017 (USD Billion)

59

Figure 24:

Global Electroporation Technique Market, By Value, Forecast, 2018-2023(USD Billion)

59

Figure 25:

Global Sonophoresis Technique Market, By Value, 2013-2017 (USD Billion)

60

Figure 26:

Global Sonophoresis Technique Market, By Value, Forecast, 2018-2023(USD Billion)

60

Figure 27:

Global Other Techniques Market, By Value, 2013-2017 (USD Billion)

61

Figure 28:

Global Other Techniques Market, By Value, Forecast, 2018-2023(USD Billion)

61

Figure 29:

Transdermal Drug Delivery System Market Size, By End User, 2017 (In %)

63

Figure 30:

Transdermal Drug Delivery System Market Size, By End User, 2023 (In %)

64

Figure 31:

Global Hospital & Clinic Transdermal Drug Delivery System Market, By Value, 2013-2017 (USD Billion)

65

Figure 32:

Global Hospital & Clinic Transdermal Drug Delivery System Market, By Value, Forecast, 2018-2023(USD Billion)

65

Figure 33:

Global Homecare Transdermal Drug Delivery System Market, By Value, 2013-2017 (USD Billion)

66

Figure 34:

Global Homecare Transdermal Drug Delivery System Market, By Value, Forecast, 2018-2023 (USD Billion)

66

Figure 35:

Global Healthcare Landscape, By Select Region

68

Figure 36:

Transdermal Drug Delivery System Market Size, By Region, 2017 (In %)

69

Figure 37:

Transdermal Drug Delivery System Market Size, By Region, 2023 (In %)

70

Figure 38:

North America Transdermal Drug Delivery System Market Size, By Value, 2013-2017 (USD Billion)

72

Figure 39:

North America Transdermal Drug Delivery System Market Size, By Value, Forecast, 2018-2023 (USD Billion)

73

Figure 40:

North America Healthcare Cost Per Capita, 2017 (USD)

74

14

List of Figures Figure No.

Figure Title

Page No.

Figure 41:

North America Population Ages 65 and above, 2012-2017 (% of Total)

74

Figure 42:

North America GDP, 2012-2017 (USD Trillion)

75

Figure 43:

North America GDP per capita, current prices, 2013-2023F (In USD)

75

Figure 44:

North America Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)

78

Figure 45:

North America Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion)

79

Figure 46:

North America Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)

80

Figure 47:

North America Transdermal Drug Delivery System Market: By Technique, By Value, 2018E-2023F (USD Billion)

81

Figure 48:

North America Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)

82

Figure 49:

North America Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)

83

Figure 50:

U.S. Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)

86

Figure 51:

U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD)

88

Figure 52:

U.S., Population ages 65 and above, 2013-2017 (% of total)

89

Figure 53:

U.S., Population ages 65 and above, Forecast (In Billions)

89

Figure 54:

U.S., Diseases developed by smoking addicts (in number)

90

Figure 55:

U.S., GDP (Current USD), 2013-2017 (In USD Trillion)

90

Figure 56:

U.S. Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)

92

Figure 57:

U.S. Transdermal Drug Delivery System Market: By Type, By Value, 2018-2023 (USD Billion)

93

Figure 58:

U.S. Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)

94

Figure 59:

U.S. Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)

95

Figure 60:

U.S. Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)

97

15

List of Figures Figure No.

Figure Title

Page No.

Figure 61:

U.S. Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)

98

Figure 62:

Canada Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)

100

Figure 63:

Canada, Expenditure on Health as a share of GDP, 2012-2017 (in %)

102

Figure 64:

Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)

102

Figure 65:

Canada, Population ages 65 and above, 2012-2017 (% of total)

102

Figure 66:

Canada Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)

104

Figure 67:

Canada Transdermal Drug Delivery System Market: By Type, By Value, 2018-2023 (USD Billion)

105

Figure 68:

Canada Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)

106

Figure 69:

Canada Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)

107

Figure 70:

Canada Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)

109

Figure 71:

Canada Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)

110

Figure 72:

North America Transdermal Drug Delivery System Market, Country Share, 2013-2017E (% of Total)

112

Figure 73:

North America Transdermal Drug Delivery System Market, Country Share, 2018F-2023F (% of Total)

112

Figure 74:

Europe Transdermal Drug Delivery System Market Size, By Value, 2013-2017 (USD Billion)

114

Figure 75:

Europe Transdermal Drug Delivery System Market Size, By Value, Forecast, 2018-2023 (USD Billion)

115

Figure 76:

Per Capita Health Expenditure, By Select Country, 2017 (USD)

117

Figure 77:

European Union, Population ages 65 and above, 2013-2017 (% of total)

117

Figure 78:

European Country Population Aged 65 and Above, 2012-2017 (% of Total)

118

Figure 79:

GDP, Europe Region, By Select Country, 2017 (In Trillion USD)

118

Figure 80:

Europe Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)

120

16

List of Figures Figure No.

Figure Title

Page No.

Figure 81:

Europe Transdermal Drug Delivery System Market: By Product, By Value, 2018E-2023F (USD Billion)

121

Figure 82:

Europe Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)

122

Figure 83:

Europe Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)

123

Figure 84:

Europe Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)

125

Figure 85:

Europe Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)

126

Figure 86:

U.K. Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)

129

Figure 87:

U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)

131

Figure 88:

U.K, Population Ages 65 and Above (% of total), 2012-2017

131

Figure 89:

U.K. Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)

133

Figure 90:

U.K. Transdermal Drug Delivery System Market: By Type, By Value, 2018-2023 (USD Billion)

134

Figure 91:

U.K. Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)

135

Figure 92:

U.K. Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)

136

Figure 93:

U.K. Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)

138

Figure 94:

U.K. Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)

139

Figure 95:

Germany Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)

141

Figure 96:

Germany, Age Structure Breakdown, 2017 (In %)

143

Figure 97:

Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)

144

Figure 98:

Germany, Population ages 65 and above, 2012-2017 (% total)

144

Figure 99:

Germany Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)

146

Figure 100:

Germany Transdermal drug Delivery System Market: By Type, By Value, 2018-2023 (USD Billion)

147

17

List of Figures Figure No.

Figure Title

Page No.

Figure 101:

Germany Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)

148

Figure 102:

Germany Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)

149

Figure 103:

Germany Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)

151

Figure 104:

Germany Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)

152

Figure 105:

Europe Transdermal Drug Delivery System Market, Country Share, Historic, 2013-2017(% of Total)

153

Figure 106:

Europe Transdermal Drug Delivery System Market, Country Share, Forecast, 2018-2023 (% of Total)

153

Figure 107:

APAC Transdermal Drug Delivery System Market Size, By Value, 2013-2017 (USD Billion)

155

Figure 108:

APAC Transdermal Drug Delivery System Market Size, By Value, Forecast, 2018-2023 (USD Billion)

156

Figure 109:

APAC, GDP, By Select Country, 2017 (In USD Trillion)

158

Figure 110:

Population ages 65 and above, APAC Region, By Select Countries, 2017 (% of total)

159

Figure 111:

Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)

159

Figure 112:

APAC Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)

162

Figure 113:

APAC Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion)

163

Figure 114:

APAC Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)

164

Figure 115:

APAC Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)

165

Figure 116:

APAC Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)

167

Figure 117:

APAC Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)

168

Figure 118:

Japan Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)

171

Figure 119:

Japan, GDP Growth Per Year, 2015-2019F (In %)

173

Figure 120:

Japan Healthcare Expenditure Outlook (2016) (%)

173

18

List of Figures Figure No.

Figure Title

Page No.

Figure 121:

Japan, Population ages 65 and above, 2012-2016 (% of total)

173

Figure 122:

Japan Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)

175

Figure 123:

Japan Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion)

176

Figure 124:

Japan Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)

177

Figure 125:

Japan Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)

178

Figure 126:

Japan Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)

180

Figure 127:

Japan Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)

181

Figure 128:

India Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)

183

Figure 129:

India, Population ages 65 and above, 2012-2017

186

Figure 130:

India, Share of Urban Population, 2012-2017 (In %)

186

Figure 131:

India, GDP Growth Per Year, 2015-2019 (In %)

187

Figure 132:

India, Total Population, 2013-2023F (In Billion)

187

Figure 133:

India Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)

189

Figure 134:

India Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion)

190

Figure 135:

India Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)

191

Figure 136:

India Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)

192

Figure 137:

India Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)

194

Figure 138:

India Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)

195

Figure 139:

China Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)

197

Figure 140:

China, Population aged 65 and above, 2012-2017 (% of total)

199

19

List of Figures Figure No.

Figure Title

Page No.

Figure 141:

China Healthcare Expenditure Outlook (2017) (%)

199

Figure 142:

China, GDP Growth Per Year, 2015-2019 (In %)

200

Figure 143:

China, Share of Urban Population, 2012-2017 (In %)

200

Figure 144:

China, Total Population, 2013-2021F (In Billion)

200

Figure 145:

China Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)

202

Figure 146:

China Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion

203

Figure 147:

China Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)

204

Figure 148:

China Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)

205

Figure 149:

China Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)

207

Figure 150:

China Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)

208

Figure 151:

APAC Transdermal Drug Delivery System Market, Country Share, 2013-2017 (% of Total)

209

Figure 152:

APAC Transdermal Drug Delivery System Market, Country Share, 2018-2023 (% of Total)

209

Figure 153:

ROW Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)

211

Figure 154:

Latin America and Caribbean, Population ages 65 and above (% of total)

213

Figure 155:

Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)

213

Figure 156:

Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)

214

Figure 157:

Middle East and North Africa, GDP, 2012-2017 (In USD Trillion)

214

Figure 158:

ROW Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)

216

Figure 159:

ROW Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion)

217

Figure 160:

ROW Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)

218

20

List of Figures Figure No.

Figure Title

Page No.

Figure 161:

ROW Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)

219

Figure 162:

ROW Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)

221

Figure 163:

ROW Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)

222

Figure 164:

Brazil Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)

224

Figure 165:

Brazil, Population ages 65 and above, 2012-17 (% of total)

225

Figure 166:

Brazil, GDP, 2012-2017 (In USD Trillion)

225

Figure 167:

Brazil Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)

227

Figure 168:

Brazil Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion)

228

Figure 169:

Brazil Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)

229

Figure 170:

Brazil Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)

230

Figure 171:

Brazil Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)

232

Figure 172:

Brazil Transdermal Drug Delivery System Market: By End user, By Value, 2018E-2023F (USD Billion)

233

Figure 173:

3 M Pharmaceutical, Net Sales, 2013-2017 (In Billion USD)

264

Figure 174:

3 M Pharmaceutical, Net Sales, By Business Sector, 2017 (In %)

264

Figure 175:

3 M Pharmaceutical, Net Sales, By Geographic Region, 2017 (In %)

264

Figure 176:

Boehringer Ingelheim, Net Sales, 2013-2017 (In Billion USD)

266

Figure 177:

Boehringer Ingelheim, Net Sales, By Business Sector, 2017 (In %)

266

Figure 178:

Boehringer Ingelheim, Net Sales, By Geographic Region, 2017 (In %)

266

Figure 179:

Mylan, Sales Revenue, 2013-2017 (In USD Billion)

268

Figure 180:

Mylan , Sales, By Business Segment, 2017 (In %)

268

21

List of Figures Figure No.

Figure Title

Page No.

Figure 181:

Mylan , By Geographic Region, 2017 In (%)

268

Figure 182:

Novartis, Sales Revenue, 2013-2017 (In USD Billion)

270

Figure 183:

Novartis, Sales, By Business Segment, 2017 (In %)

270

Figure 184:

Novartis, By Geographic Region, 2017 In (%)

270

Figure 185:

GlaxoSmithKline, Sales Revenue, 2013-2017 (In USD Billion)

272

Figure 186:

GlaxoSmithKline, Sales, By Business Segment, 2017 (In %)

272

Figure 187:

GlaxoSmithKline, By Geographic Region, 2017 In (%)

272

Figure 188:

Johnson& Johnson, Sales Revenue, 2013-2017 (In USD Billion)

276

Figure 189:

Johnson & Johnson, Sales, By Business Segment, 2017 (In %)

276

Figure 190:

Johnson & Johnson, By Geographic Region, 2017 In (%)

276

Figure 191:

Bayer, Sales Revenue, 2013-2017 (USD Billion)

278

Figure 192:

Bayer, Sales Revenue, 2013-2017 (USD Billion)

278

Figure 193:

Bayer , Sales, By Geographic region, FY ended March 2017 (%)

278

Table A:

Parameters affecting selection of drugs in TDDS

30

Table B:

Germany, Healthcare Related Statistics, 2017

143

Table C:

Global Access to Healthcare Index, Ranking of Select Countries in Asia Pacific Region, 2017 (score out of 10)

160

22

Research Methodology For our study on Transdermal Drug Delivery System Market, we have conducted comprehensive secondary research followed by an extensive primary research.

In the process of

secondary research, we have

scrutinized industry documents, accessed from open sources, premium paid databases (Bloomberg, Thomson Reuters, Factiva) and our internal knowledge base. In the process of primary research, we have interviewed various industry experts across the value chain of medical device industry.

Market size of the actual period (2013-2017) has been evaluated on the basis of growth trends of the industry in the last five years, and confirming the findings through primary research. Annual reports of the companies were scanned to further validate the market size and to estimate the size of various other enduser sectors. Market sizing and growth in the forecast period (2018-2023) is estimated through product mapping, application in end-user industries, growth of allied sectors and historical growth pattern of the industry. All the relevant data points/ statistics in the forecast period are validated through relevant and reliable primary sources.

Report Focus: Transdermal Drug Delivery System Market - By Type (Patches, Gels) - By Technique(Iontophoresis, Electroporation, Sonophoresis and Others) - By End User- (Hospital & Clinic, Homecare)

- By Region (North America, Europe, Asia Pacific and Rest of the World) - By Country ( U.S., Canada, U.K, Germany, India, China, Japan and Brazil).

Companies Contacted: GlaxoSmithKline, Fortis Hospital 23

Global Transdermal Drug Delivery System Market Manifested cure for diseases, having threatening consequences, has been driving the demand growth in historic period.

Figure 2: Global Transdermal Drug Delivery System System Market Size, By Value, 2013-2017 (USD Billion) CAGR 2013-2017 xx%

2013

2014

2015

2016

2017

Source: Azoth Analytics Estimates Xx Xx Xx Xx Xx Xx

24

Global Transdermal Drug Delivery System Market Increase in research and development along with growing generic market for transdermal drugs is likely

to drive the demand growth in forecast period.

Figure 3: Global Transdermal Drug Delivery System System Market Size, By Value, Forecast, 2018-2023 (USD Billion) CAGR 2018-2023 xx%

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates Xx Xx Xx Xx Xx Xx

25

Global Trandermal Global Drug Delivery Systems Devices Market, By Value Transdermal Drug Replacement Market, By Patches Figure 15: Global Patches Type Market, By Value, 2013-

Figure 16: Global Patches Type Market, By Value, Forecast,

2017 (USD Billion)

2018-2023(USD Billion)

2013

2014

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2015

2016

2017

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates Xx Xx Xx Xx Xx Xx Xx

26

Global Trandermal Drug Delivery SystemsDrug Replacement Global Transdermal Market, ByDevices Gels Market, By Value Figure 17: Global Gels Type Market, By Value, 2013-

Figure 18: Global Gels Type Market, By Value,

2017 (USD Billion)

Forecast, 2018-2023(USD Billion)

2013

2014

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2015

2016

2017

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates Xx Xx Xx Xx Xx Xx Xx

27

Global Transdermal Drug Market, By Technique

Global Trandermal Drug Delivery Systems Replacement Devices Market, By Value (Iontophoresis) Figure 21: Global Iontophoresis Technique TDDS

Figure 22: Global Iontophoresis Technique TDDS Market,

Market, By Value, 2013-2017 (USD Billion)

By Value, Forecast, 2018-2023(USD Billion)

2013

Xx

2014

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2015

2016

2017

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates

Xx Xx Xx Xx Xx Xx

28

Global Transdermal Drug Market, By Technique

Global Trandermal Drug Delivery Systems Replacement Devices Market, By Value (Electroporation) Figure 23: Global Electroporation Technique Market, By

Figure 24: Global Electroporation Technique Market, By

Value, 2013-2017 (USD Billion)

Value, Forecast, 2018-2023(USD Billion)

2013

2014

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2015

2016

2017

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates Xx Xx Xx Xx Xx Xx Xx

29

Global Transdermal Drug Market, By Technique

Global Trandermal Drug Delivery Systems Replacement Devices Market, By Value (Sonophoresis) Figure 25: Global Sonophoresis Technique Market, By

Figure 26: Global Sonophoresis Technique Market, By

Value, 2013-2017 (USD Billion)

Value, Forecast, 2018-2023(USD Billion)

2013

2014

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2015

2016

2017

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates Xx Xx Xx Xx Xx Xx Xx

30

Global Transdermal Drug Market, By Technique

Global Trandermal Drug Delivery Systems Replacement Devices Market, By Value (Others) Figure 27: Global Other Techniques Market, By Value,

Figure 28: Global Other Techniques Market, By Value,

2013-2017 (USD Billion)

Forecast, 2018-2023(USD Billion)

2013

2014

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2015

2016

2017

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates Xx Xx Xx Xx Xx Xx Xx

31

Global Trandermal Delivery SystemsDrug Replacement Devices Market, By Value Global Drug Hospital Transdermal Delivery System Market Figure 31: Global Hospital & Clinic Transdermal Drug

Figure 32: Global Hospital & Clinic Transdermal Drug Delivery

Delivery System Market, By Value, 2013-2017 (USD Billion)

System Market, By Value, Forecast, 2018-2023(USD Billion)

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2013

Xx

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates

Xx Xx Xx Xx Xx Xx

32

Global Trandermal Drug Delivery Systems Dug Replacement Devices Market, By Value Global Homecare Transdermal Delivery System Market Figure 33: Global Homecare Transdermal Drug Delivery

Figure 34: Global Homecare Transdermal Drug Delivery System

System Market, By Value, 2013-2017 (USD Billion)

Market, By Value, Forecast, 2018-2023 (USD Billion)

2013

Xx

2014

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2015

2016

2017

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates

Xx Xx Xx Xx Xx Xx

33

North America Transdermal Drug Delivery System Market Overview Growing prevalence of CVD diseases, stress, hormonal disturbance and increased per capita expenditure on healthcare has been driving regional demand .

Figure 38: North America Transdermal Drug Delivery System Market Size, By Value, 2013-2017 (USD Billion) CAGR 2013-2017 xx%

2013

2014

2015

2016

2017

Source: Azoth Analytics Estimates Xx Xx Xx Xx Xx Xx

34

North America Transdermal Drug Delivery System Market Overview Concentration of major companies in the region as well as partnerships and collaboration with key players is anticipated to drive the market.

Figure 39: North America Transdermal Drug Delivery System Market Size, By Value, Forecast, 2018-2023 (USD Billion)

CAGR 2018-2023 xx%

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates Xx Xx Xx Xx Xx Xx

35

North America Transdermal Drug Delivery System Market, By Type Figure 44: North America Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion) CAGR 2013-2017 Patches: xx% Gels: xx%

2013

2014

2015

2016

Patches

2017

Gels

2013

2014

2015

2016

2017

Patches

xx

xx

xx

xx

xx

Gels

xx

xx

xx

xx

xx

Xx Xx Xx Xx

Source: Azoth Analytics Estimates

36

North America Transdermal Drug Delivery System Market, By Type Figure 45: North America Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion)

CAGR 2018-2023 Patches : xx% Gels :xx%

2018

2019

2020

2021

Patches

2022

2023

Gels

2018

2019

2020

2021

2022

2023

Patches

xx

xx

xx

xx

xx

xx

Gels

xx

xx

xx

xx

xx

xx

Xx Xx Xx

Source: Azoth Analytics Estimates

37

North America Transdermal Drug Delivery System Market, By Technique Figure 46: North America Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion) CAGR 2013-2017 Iontophoresis: xx% Electroporation: xx% Sonophoresis: xx% Others: xx%

2013

2014 Iontophoresis

2015 Electroporation

2016 Sonophoresis Others

2017

2013

2014

2015

2016

2017

Iontophoresis

xx

xx

xx

xx

xx

Electroporation

xx

xx

xx

xx

xx

Sonophoresis

xx

xx

xx

xx

xx

Others

xx

xx

xx

xx

xx

Xx Xx Xx Xx

Source: Azoth Analytics Estimates

38

North America Transdermal Drug Delivery System Market, By Technique Figure 47: North America Transdermal Drug Delivery System Market: By Technique, By Value, 2018E-2023F (USD Billion)

CAGR 2013-2017 Iontophoresis: xx% Electroporation: xx% Sonophoresis: xx% Others: xx%

2018

2019 Iontophoresis

2020 Electroporation

2013

2021 Sonophoresis

2022 Others

2023

2014

2015

2016

2017

Iontophoresis

xx

xx

xx

xx

xx

xx

Electroporation

xx

xx

xx

xx

xx

xx

Sonophoresis

xx

xx

xx

xx

xx

xx

Others

xx

xx

xx

xx

xx

xx

Xx Xx Xx Xx

Source: Azoth Analytics Estimates

39

North America Transdermal Drug Delivery System Market, By End User Figure 48: North America Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)

CAGR 2013-2017 Hospital & Clinic: xx% Homecare: xx%

2013

2014

2015

Hospital & Clinic

2016

2017

Homecare

2013

2014

2015

2016

2017

Hospital & Clinic

xx

xx

xx

xx

xx

Homecare

xx

xx

xx

xx

xx

Xx Xx Xx Xx Source: Azoth Analytics Estimates

40

North America Transdermal Drug Delivery System Market, By End User Figure 49: North America Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)

CAGR 2018-2023 Hospital & Clinic: xx% Homecare: xx%

2018

2019

2020

2021

Hospital & Clinic

2022

2023

Homecare

2018

2019

2020

2021

2022

2023

Hospital & Clinic

xx

xx

xx

xx

xx

xx

Homecare

xx

xx

xx

xx

xx

xx

Xx Xx Xx Xx Source: Azoth Analytics Estimates

41

U.S. Transdermal Drug Delivery System Market, By Value Figure 50: U.S. Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)

2013

2014

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2015

2016

2017 2018 2019 Source: Azoth Analytics Estimates

2020

2021

2022

2023

Xx Xx Xx Xx •

.

Xx Xx Xx

42

U.S. Transdermal Drug Delivery System Market, By Type Figure 56: U.S. Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion) CAGR 2013-2017 Patches: xx% Gels: xx%

2013

2014

2015

2016

Patches

2017

Gels

2013

2014

2015

2016

2017

Patches

xx

xx

xx

xx

xx

Gels

xx

xx

xx

xx

xx

Xx Xx Xx Xx

Source: Azoth Analytics Estimates

43

U.S. Transdermal Drug Delivery System Market, By Type Figure 57: U.S. Transdermal Drug Delivery System Market: By Type, By Value, 2018-2023 (USD Billion) CAGR 2018-2023 Patches: xx% Gels: xx%

2018

2019

2020

2021

2022

Patches

2023

Gels

2018

2019

2020

2021

2022

2023

Patches

xx

xx

xx

xx

xx

xx

Gels

xx

xx

xx

xx

xx

xx

Xx Xx Xx Xx

Source: Azoth Analytics Estimates

44

U.S. Transdermal Drug Delivery System Market, By Technique Figure 58: U.S. Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion) CAGR 2013-2017 Iontophoresis: xx% Electroporation: xx% Sonophoresis: xx% Others: xx%

2013

2014 Iontophoresis

2015 Electroporation

2016 Sonophoresis Others

2017

2013

2014

2015

2016

2017

Iontophoresis

xx

xx

xx

xx

xx

Electroporation

xx

xx

xx

xx

xx

Sonophoresis

xx

xx

xx

xx

xx

Others

xx

xx

xx

xx

xx

Source: Azoth Analytics Estimates

45

U.S. Transdermal Drug Delivery System Market, By Technique Figure 59: U.S. Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion) CAGR 2018-2023 Iontophoresis: xx% Electroporation: xx% Sonophoresis: xx% Others: xx%

2018

2019

2020

Iontophoresis

2021

Electroporation

2022

Sonophoresis

2023

Others

2018

2019

2020

2021

2022

2023

Iontophoresis

xx

xx

xx

xx

xx

xx

Electroporation

xx

xx

xx

xx

xx

xx

Sonophoresis

xx

xx

xx

xx

xx

xx

Others

xx

xx

xx

xx

xx

xx

Source: Azoth Analytics Estimates

46

U.S. Transdermal Drug Delivery System Market, By End User Figure 60: U.S. Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion) CAGR 2013-2017 Hospital & Clinic: xx% Homecare: xx%

2013

2014

2015

2016

Hospital & Clinic

2017

Homecare

2013

2014

2015

2016

2017

Hospital & Clinic

xx

xx

xx

xx

xx

Homecare

xx

xx

xx

xx

xx

Xx Xx Xx Xx

Source: Azoth Analytics Estimates

47

U.S. Transdermal Drug Delivery System Market, By End User Figure 61: U.S. Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)

CAGR 2018-2023 Hospital & Clinic: xx% Homecare: xx%

2018

2019

2020

2021

Hospital & Clinic

2022

2023

Homecare

2018

2019

2020

2021

2022

2023

Hospital & Clinic

xx

xx

xx

xx

xx

xx

Homecare

xx

xx

xx

xx

xx

xx

Xx

Xx Xx Xx Xx Source: Azoth Analytics Estimates

48

About Azoth Analytics Pvt Ltd.

Azoth Analytics is a business research and analytics firm that creates in-depth research reports and provides customized research solutions and consultancy services. Verticals in which Azoth Analytics specializes include healthcare and pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food & beverages and technology. Azoth creates comprehensive and in-depth research reports by recording, interpreting and analyzing information. Strategic market sizing and data dredging Technique include secondary research, and primary research (interviews with management personnel and industry experts).

Disclaimer: Azoth Analytics report information is based mainly on interviews and therefore, is subject to fluctuation. Azoth Analytics therefore, takes no responsibility for any incorrect information supplied to us by industry experts, manufacturers or users. Azoth does not warranty the completeness of the information and data. Also, analysis

provided in the report are meant for customers’ internal use only and not for general publication or disclosure to third parties.

49